Search
pipeline-october-2023
Dynagito
DYNAGITO Infographic
Payments_to_patienten_organisations_2022
Partnering in Parasitology MAY 2024 CORP_0.pdf
Guide to Partnering with AH
enabling_todays-science_infographic
Manifesto-Infographics
Risk Factors of Venous Thromboembolism (VTE)_0.pdf
Respiratory Research and Development Timeline.pdf
vesuto_ers2018.pdf
Respiratory_Partnering_Interests_2018-12.pdf
Symptoms of VTE.pdf
Most common risk factors for VTE.pdf
Most common risk factors for VTE.pdf
Most common risk factors for VTE.pdf
Praxbind® – the specific reversal agent to dabigatran.pdf
Candice is moving to Germany
Are you considering a career at Boehringer Ingelheim? Find out why Candice loves working here. For more talent insights, visit our Careers Page.
Vikas joined from hospital sector
Are you considering moving into pharmaceuticals for the first time? Vikas made the leap and has never looked back.
IL-11 inhibitor antibody clinical development launched
Boehringer Ingelheim has launched clinical development of its first-in-class IL-11 inhibitor antibody as a fibrotic disease treatment
A guide to hidradenitis suppurativa (HS)
Hidradenitis suppurativa (HS) is a long-term, inflammatory, recurrent, skin condition that causes painful inflamed nodules, or abscesses on the skin
ACR19 Autoimmune Trial
ACR Congress 2019 abstract analysing a subgroup of patients with autoimmune diseases in the INBUILD® trial of nintedanib in patients with PF-ILF
Rabies wildlife 5 things to know
Rabies in wildlife - 5 things to know to protect yourself and your pet
Cristian Torreblanca
Cristian Torreblanca Estrada is a Corporate Global Facilities and Engineering Senior Manager Controller in Germany – with plans for growth across the global business.